Search

Author/Creator Zhang, Pingkuan

1. Brigatinib Dose Rationale in Anaplastic Lymphoma Kinase–Positive Non‐Small Cell Lung Cancer: Exposure–Response Analyses of Pivotal ALTA Study. (26th December 2020)

Authors:
Gupta, Neeraj; Wang, Xiaohui; Offman, Elliot; Rich, Benjamin; Kerstein, David; Hanley, Michael; Diderichsen, Paul M.; Zhang, Pingkuan; Venkatakrishnan, Karthik
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 9:Number 12(2020)
Page Start:
718
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial. Issue 7 (July 2016)

Authors:
Planchard, David; Besse, Benjamin; Groen, Harry J M; Souquet, Pierre-Jean; Quoix, Elisabeth; Baik, Christina S; Barlesi, Fabrice; Kim, Tae Min; Mazieres, Julien; Novello, Silvia; Rigas, James R; Upalawanna, Allison; D'Amelio, Anthony M; Zhang, Pingkuan; Mookerjee, Bijoyesh; Johnson, Bruce E
Journal:
Lancet oncology
Issue:
Volume 17:Issue 7(2016:Jul.)
Page Start:
984
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. Issue 10 (October 2017)

Authors:
Planchard, David; Smit, Egbert F; Groen, Harry J M; Mazieres, Julien; Besse, Benjamin; Helland, Åslaug; Giannone, Vanessa; D'Amelio, Anthony M; Zhang, Pingkuan; Mookerjee, Bijoyesh; Johnson, Bruce E
Journal:
Lancet oncology
Issue:
Volume 18:Issue 10(2017:Oct.)
Page Start:
1307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor–naive ALK + non−small cell lung cancer (ALTA-1L). (May 2021)

Authors:
Garcia Campelo, Maria Rosario; Lin, Huamao M.; Zhu, Yanyan; Pérol, Maurice; Jahanzeb, Mohammad; Popat, Sanjay; Zhang, Pingkuan; Camidge, D. Ross
Journal:
Lung cancer
Issue:
Volume 155(2021)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations. (May 2023)

Authors:
Christopoulos, Petros; Prawitz, Thibaud; Hong, Jin-Liern; Lin, Huamao M.; Hernandez, Luis; Jin, Shu; Tan, Min; Proskorovsky, Irina; Lin, Jianchang; Zhang, Pingkuan; Patel, Jyoti D.; Ou, Sai-Hong I.; Thomas, Michael; Stenzinger, Albrecht
Journal:
Lung cancer
Issue:
Volume 179(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Mobocertinib in previously treated patients with EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): updated results from a phase 1/2 study. (April 2023)

Authors:
Popat, Sanjay; Ramalingam, Suresh; Zhou, Caicun; Kim, Tae; Yang, James; Riely, Gregory; Mekhail, Tarek; Nguyen, Danny; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Misch, Daniel; Kaur, Manmit; Bunn, Veronica; Lin, Huamao; Zhang, Pingkuan; Jänne, Pasi
Journal:
Lung cancer
Issue:
Volume 178(2023)Supplement 1
Page Start:
S35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Overall survival indirect treatment comparison between brigatinib and alectinib for the treatment of front-line anaplastic lymphoma kinase–positive non–small cell lung cancer using data from ALEX and final results from ALTA-1L. (2nd September 2022)

Authors:
Reckamp, Karen L.; Lin, Huamao M.; Cranmer, Holly; Wu, Yanyu; Zhang, Pingkuan; Kay, Stephen; Walton, Laura J.; Shen, Junwu; Popat, Sanjay; Camidge, D. Ross
Journal:
Current medical research and opinion
Issue:
Volume 38:Number 9(2022)
Page Start:
1587
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study. Issue 1 (1st January 2018)

Authors:
Kim, Jae-Weon; Mahner, Sven; Wu, Ling-Ying; Shoji, Tadahiro; Kim, Byoung-Gie; Zhu, Jian-Qing; Takano, Tadao; Park, Sang-Yoon; Kong, Bei-Hua; Wu, Qiang; Wang, Kung-Liahng; Ngan, Hextan YS; Liu, Ji-Hong; Wei, Li-Hui; Mitrica, Ionel; Zhang, Pingkuan; Crescenzo, Rocco; Wang, Qiong; Cox, Charles J.; H...
Journal:
International journal of gynecological cancer
Issue:
Volume 28:Issue 1(2018)
Page Start:
2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗